PERFECT MEDICAL (01830) announced that it expects shareholder profit attributable for the six months ending September 30, 2025, to range between HKD 93 million and HKD 98 million, compared to HKD 141 million recorded in the same period ending September 30, 2024. However, the projected shareholder profit for the current period is expected to show an increase of no less than 40% compared to the approximately HKD 66 million recorded in the second half of the 2025 fiscal year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments